Can NK cells be a therapeutic target in human type 1 diabetes? (Q37315687)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979518%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

review article

1 reference

title

Can NK cells be a therapeutic target in human type 1 diabetes? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979518%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979518%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Cecilia Fondelli

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979518%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Alberto Falorni

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979518%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

language of work or name

English

0 references

publication date

1 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979518%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979518%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979518%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979518%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

2961-2963

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979518%20AND%20SRC:MED&resulttype=core&format=json

Deficiencies in gut NK cell number and function precede diabetes onset in BB rats

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

NK3-like NK cells are involved in protective effect of polyinosinic-polycytidylic acid on type 1 diabetes in nonobese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

Regulation of Autoimmune Diabetes by Complete Freund's Adjuvant Is Mediated by NK Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

Type 1 diabetes: new perspectives on disease pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

7 January 2021

Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

7 January 2021

Target cell defense prevents the development of diabetes after viral infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

7 January 2021

Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

7 January 2021

Impairment of NK cell function by NKG2D modulation in NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

7 January 2021

NKG2D blockade prevents autoimmune diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

7 January 2021

Critical role for IFN-γ in natural killer cell-mediated protection from diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

7 January 2021

NK cells promote islet allograft tolerance via a perforin-dependent mechanism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

7 January 2021

Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

7 January 2021

Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

7 January 2021

Evidence that the reduced number of natural killer cells in type 1 (insulin-dependent) diabetes may be genetically determined

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

7 January 2021

Alterations in lymphocyte subpopulations in type 1 (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

7 January 2021

Immune responses to insulin and lymphocyte subclasses at diagnosis of insulin-dependent diabetes and one year later

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

7 January 2021

Natural killer cells in insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

7 January 2021

Cytotoxic activity in children with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

7 January 2021

Altered natural killer cells in type 1 diabetic patients.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

7 January 2021

Association of MHC Class I chain-related A (MIC-A) gene polymorphism with Type I diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

7 January 2021

Two distinct MICA gene markers discriminate major autoimmune diabetes types

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

7 January 2021

A basolateral sorting motif in the MICA cytoplasmic tail.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838851

7 January 2021

Identifiers

DOI

10.1002/EJI.200838851

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979518%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference